Nobio and Supergum to Prototype and Test Protective Face Masks Against Viruses
Nobio Ltd. and Supergum (1983) Ltd. today announced an agreement to rapidly prototype and test an antiviral protective mask, combining Nobio's revolutionary antimicrobial technology and Supergum's market leading CBRN (chemical, biological, radiological and nuclear) breathing protection products.
Nobio's technology is on the cutting edge of antimicrobial research, utilizing patented nano-particles to transform common materials into antimicrobial, indefinitely. Products for common dental procedures recently received FDA clearance. Supergum is the leading supplier of CBRN solutions to the Israeli Government and the Israel Defense Forces.
Under the agreement, the parties will collaborate to quickly prototype and test facemasks utilizing Nobio's technology, intended to protect emergency workers, medical personnel, high-risk population and others against various microbial pathogens, including the coronavirus (COVID-19).
"The ongoing coronavirus crisis requires industry to take aggressive measures to help public health authorities defeat this pandemic and make these critical initiatives a priority," said in a joint statement, Ilan Gescheit, Supergum CEO and Yoram Ashery, Nobio CEO. "Face masks with active antiviral protection are urgently needed and to our knowledge are not yet available on the market."